These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 23112960)

  • 41. Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths.
    Makoschey B; van Kilsdonk E; Hubers WR; Vrijenhoek MP; Smit M; Wichgers Schreur PJ; Kortekaas J; Moulin V
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004550. PubMed ID: 27031621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study.
    Rusnak JM; Gibbs P; Boudreau E; Clizbe DP; Pittman P
    Vaccine; 2011 Apr; 29(17):3222-9. PubMed ID: 21354483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rift Valley fever vaccine--antibody and immune response in cattle to a live and an inactivated vaccine.
    Barnard BJ
    J S Afr Vet Assoc; 1979 Sep; 50(3):155-7. PubMed ID: 551199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pathogenesis of Rift Valley fever.
    Ikegami T; Makino S
    Viruses; 2011 May; 3(5):493-519. PubMed ID: 21666766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves.
    Morrill JC; Laughlin RC; Lokugamage N; Wu J; Pugh R; Kanani P; Adams LG; Makino S; Peters CJ
    Vaccine; 2013 Oct; 31(43):4988-94. PubMed ID: 23994375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
    Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Rift Valley fever].
    Pépin M;
    Med Mal Infect; 2011 Jun; 41(6):322-9. PubMed ID: 21295425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chimaeric Rift Valley Fever Virus-Like Particle Vaccine Candidate Production in Nicotiana benthamiana.
    Mbewana S; Meyers AE; Rybicki EP
    Biotechnol J; 2019 Apr; 14(4):e1800238. PubMed ID: 30488669
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity and safety studies of an inactivated vaccine against Rift Valley fever.
    Ronchi GF; Testa L; Iorio M; Pinoni C; Bortone G; Dondona AC; Rossi E; Capista S; Mercante MT; Morelli D; Di Ventura M; Monaco F
    Acta Trop; 2022 Aug; 232():106498. PubMed ID: 35513072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Productive Propagation of Rift Valley Fever Phlebovirus Vaccine Strain MP-12 in Rousettus aegyptiacus Fruit Bats.
    Balkema-Buschmann A; Rissmann M; Kley N; Ulrich R; Eiden M; Groschup MH
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30513679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Innate immune response to Rift Valley fever virus in goats.
    Nfon CK; Marszal P; Zhang S; Weingartl HM
    PLoS Negl Trop Dis; 2012; 6(4):e1623. PubMed ID: 22545170
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.
    Said A; Elmanzalawy M; Ma G; Damiani AM; Osterrieder N
    Virol J; 2017 Aug; 14(1):154. PubMed ID: 28807043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.
    Soi RK; Rurangirwa FR; McGuire TC; Rwambo PM; DeMartini JC; Crawford TB
    Clin Vaccine Immunol; 2010 Dec; 17(12):1842-9. PubMed ID: 20876822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular biology and genetic diversity of Rift Valley fever virus.
    Ikegami T
    Antiviral Res; 2012 Sep; 95(3):293-310. PubMed ID: 22710362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice.
    Papin JF; Verardi PH; Jones LA; Monge-Navarro F; Brault AC; Holbrook MR; Worthy MN; Freiberg AN; Yilma TD
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14926-31. PubMed ID: 21873194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breaking the chain: Rift Valley fever virus control via livestock vaccination.
    Bird BH; Nichol ST
    Curr Opin Virol; 2012 Jun; 2(3):315-23. PubMed ID: 22463980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination.
    Wilson WC; Bawa B; Drolet BS; Lehiy C; Faburay B; Jasperson DC; Reister L; Gaudreault NN; Carlson J; Ma W; Morozov I; McVey DS; Richt JA
    Vet Microbiol; 2014 Aug; 172(1-2):44-50. PubMed ID: 24856133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels.
    Daouam S; Ghzal F; Naouli Y; Tadlaoui KO; Ennaji MM; Oura C; El Harrak M
    BMC Vet Res; 2016 Jul; 12(1):154. PubMed ID: 27457539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Further Characterization of Rio Grande Virus and Potential for Cross Reactivity with Rift Valley Fever Virus Assays.
    Szymczak MS; Reeves WK; Miller MM
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rift valley Fever in Kruger national park: do buffalo play a role in the inter-epidemic circulation of virus?
    Beechler BR; Bengis R; Swanepoel R; Paweska JT; Kemp A; van Vuren PJ; Joubert J; Ezenwa VO; Jolles AE
    Transbound Emerg Dis; 2015 Feb; 62(1):24-32. PubMed ID: 24330522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.